AAAAAA
Results:
1-7
|
Results: 7
Authors:
Stier, DM
Gause, D
Joseph, WS
Schein, JR
Broering, JM
Warolin, KL
Doyle, JJ
Citation: Dm. Stier et al., Patient satisfaction with oral versus nonoral therapeutic approaches in onychomycosis, J AM POD M, 91(10), 2001, pp. 521-527
Authors:
Kleerekoper, M
Schein, JR
Citation: M. Kleerekoper et Jr. Schein, Comparative safety of bone remodeling agents with a focus on osteoporosis therapies, J CLIN PHAR, 41(3), 2001, pp. 239-250
Authors:
Sewell, K
Schein, JR
Citation: K. Sewell et Jr. Schein, Osteoporosis therapies for rheumatoid arthritis patients: Minimizing gastrointestinal side effects, SEM ARTH RH, 30(4), 2001, pp. 288-297
Authors:
Cappell, MS
Schein, JR
Citation: Ms. Cappell et Jr. Schein, Diagnosis and treatment of nonsteroidal anti-inflammatory drug-associated upper gastrointestinal toxicity, GASTRO CLIN, 29(1), 2000, pp. 97
Authors:
Satterfield, T
Johnson, SM
Slovic, P
Neil, N
Schein, JR
Citation: T. Satterfield et al., Perceived risks and reported behaviors associated with osteoporosis and its treatment, WOMEN HEAL, 31(4), 2000, pp. 21-40
Authors:
Lubeck, DP
Gause, D
Schein, JR
Prebil, LE
Potter, LP
Citation: Dp. Lubeck et al., A health-related quality of life measure for use in patients with onychomycosis: a validation study, QUAL LIFE R, 8(1-2), 1999, pp. 121-129
Authors:
Ballantyne, CM
Herd, JA
Ferlic, LL
Dunn, JK
Farmer, JA
Jones, PH
Schein, JR
Gotto, AM
Citation: Cm. Ballantyne et al., Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy, CIRCULATION, 99(6), 1999, pp. 736-743
Risultati:
1-7
|